OliX Pharmaceuticals Inc.

In News

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

GlobeNewswire - Feb 03, 2026

OliX secures ₩115 billion investment through convertible preferred shares - koreabiomed.com

koreabiomed.com - Aug 20, 2025

OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications - Business Wire

Business Wire - Feb 10, 2025

Driving drug development through next-generation oligonucleotide technology - Nature

Nature - Sep 02, 2020

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate - Yahoo Finance

Yahoo Finance - Feb 10, 2021

Eli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASH - Pharmaceutical Technology

Pharmaceutical Technology - Feb 11, 2025

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment - BioSpace

BioSpace - Apr 28, 2023

OliX Pharmaceuticals announces positive results of phase 1 study of safety and tolerability of OLX10212 - Modern Retina

Modern Retina - Dec 12, 2023

Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH - Fierce Biotech

Fierce Biotech - Feb 10, 2025

OliX launches mCureX for mRNA vaccines - Drug Discovery News

Drug Discovery News - Feb 09, 2021

Olix wins $630M deal from Eli Lilly for phase I MASH asset - BioWorld MedTech

BioWorld MedTech - Feb 11, 2025

OliX Advancing in Nucleic Acid Therapeutics - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Feb 05, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment